The submitted test runs on the firm's point-of-care instrument and detects four respiratory pathogens within 10 minutes directly from patient nasal swab samples.

The program is intended to advance the development of antigen tests that can be used in homes and at the point-of-care to aid the detection of dangerous infections.

Under the agreement, Tempus and Renalytix will work with US healthcare systems to make the KidneyintelX.dkd test more available to order within existing clinical workflows.